Mary Flynn

Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort

Jeffrey L. Seeburger, Daniel Holder, Marc Combrinck et al. · Journal of Alzheimer s Disease · 2015 · 99 citations

Life Sciences, Neurology, Neuroscience +17

Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX‐2 Versus COX‐1 in Healthy Subjects

Jules I. Schwartz, Aimée Dallob, Patrick Larson et al. · The Journal of Clinical Pharmacology · 2008 · 46 citations

Medicine, Pharmacology, Pharmacotherapy +12

O4–03–02: The gamma secretase inhibitor MK–0752 acutely and significantly reduces CSF Abeta40 concentrations in humans

Laura Rosen, Julie A. Stone, Andrew Plump et al. · Alzheimer s & Dementia · 2006 · 32 citations

Medicine, Pharmacokinetics, Pharmacology +17

Calculated insulin resistance correlates with stone-forming urinary metabolic changes and greater stone burden in high-risk stone patients

Timothy Tran, Mary Flynn, John O’Bell et al. · Clinical Nephrology · 2016 · 14 citations

Medicine, Nephrology, Urology +17

Retrospective Quality Improvement Study of Insulin-Induced Hypoglycemia and Implementation of Hospital-Wide Initiatives

Carter Shelton, Andrew P. Demidowich, Mahsa Motevalli et al. · Journal of Diabetes Science and Technology · 2021 · 10 citations · Full text

Health Professions, Health Services Administration, Pharmacoeconomics +17